- KR₩81bn
- KR₩85bn
- KR₩93bn
- 40
- 56
- 32
- 37
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 3 | ||
Price to Tang. Book | 3.69 | ||
Price to Free Cashflow | 11.65 | ||
Price to Sales | 0.87 | ||
EV to EBITDA | 7.16 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 34.34% | ||
Return on Equity | 23.27% | ||
Operating Margin | 10.7% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 103,802.66 | 100,966.11 | 102,710.44 | 104,234.95 | 93,013.75 | n/a | n/a | -1.93% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | +66.11 | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
JW SHINYAK CORPORATION is a Korea-based company principally engaged in the manufacture and distribution of pharmaceuticals. The Company’s main products portfolio consists of antibiotics, anesthetics, respiratory remedies, urology remedies, cardiovascular remedies, allergy remedies, digestive remedies, anti-inflammatory drugs, antivirals as well as acne remedies, among others. In addition, it also involves in the provision of cosmetics, such as creams, cleansers, toners, essences, lotions and others.
Directors
- Seung Ho Baek CEO (55)
- Yong Mun Choi OTH (63)
- Yin Sik Lee OTH (66)
- Cheol Wung Han DRC (42)
- Sang Yeong Han DRC (52)
- Jong Ho Lee DRC (84)
- Byeong Cheol Choi NID (64)
- Gyu Heon Kim NID (58)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 13th, 1981
- Public Since
- February 11th, 2003
- No. of Shareholders
- 19,658
- No. of Employees
- 226
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ
- Shares in Issue
- 53,219,667

- Address
- 38, Gwacheon-daero 7-gil, GWACHEON, 13840
- Web
- https://www.jw-shinyak.co.kr/
- Phone
- +82 28406777
- Auditors
- Ernst & Young Han Young
Upcoming Events for 067290
Q2 2025 JW Shinyak Corp Earnings Release
Similar to 067290
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
AHN-GOOK PHARMACEUTICAL Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 21:30 UTC, shares in JW Shinyak are trading at KR₩1,518. This share price information is delayed by 15 minutes.
Shares in JW Shinyak last closed at KR₩1,518 and the price had moved by -12.95% over the past 365 days. In terms of relative price strength the JW Shinyak share price has underperformed the FTSE Developed Asia Pacific Index by -11.01% over the past year.
There is no consensus recommendation for this security.
Find out moreJW Shinyak does not currently pay a dividend.
JW Shinyak does not currently pay a dividend.
JW Shinyak does not currently pay a dividend.
To buy shares in JW Shinyak you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩1,518, shares in JW Shinyak had a market capitalisation of KR₩81bn.
Here are the trading details for JW Shinyak:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 067290
Based on an overall assessment of its quality, value and momentum JW Shinyak is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like JW Shinyak. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +19.49%.
As of the last closing price of KR₩1,518, shares in JW Shinyak were trading -0.43% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The JW Shinyak PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩1,518.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
JW Shinyak's management team is headed by:
- Seung Ho Baek - CEO
- Yong Mun Choi - OTH
- Yin Sik Lee - OTH
- Cheol Wung Han - DRC
- Sang Yeong Han - DRC
- Jong Ho Lee - DRC
- Byeong Cheol Choi - NID
- Gyu Heon Kim - NID